Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Soroka University Medical Center |
---|---|
Information provided by: | Soroka University Medical Center |
ClinicalTrials.gov Identifier: | NCT00397267 |
We assume that the combination of systemic steroids and inhaled steroid in the first hour of treatment in the ER will decrease the admission rate and improve faster the pulmonary function.
120 patients refferd to the ER due to asthma attack aged 18-60 with PFR < 60% 0o predicted will participate in the study after giving informed consent.
The usual treatment in the ER is inhalation of Beta 2 short acting and I.V solumedrol 120 mg . The study group will recieve in addition 3 inhalation of Budesonide 1000 microgram each during the first hour.
The controlled group will recieve Nacl 0.9% PFR will be followed 0 30 60 120 min.
Condition | Intervention | Phase |
---|---|---|
Asthma Exacerbation |
Drug: inhalation of corticosteroids |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Placebo Control, Parallel Assignment, Efficacy Study |
Ages Eligible for Study: | 18 Years to 60 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Dov Heimer M.D. Heimer, AS. Proffessor | 972 8 6400807 | heimerd@clalit.org.il |
Contact: LUNA Avnon, M.D | 972 8 6403024 |
Israel | |
ER Soroka Med Center | |
Beer-Sheva, Israel, P.O.Box 151 |
Principal Investigator: | Dov Heimer, M.D | BGU Soroka medical center |
Study ID Numbers: | SOR440906CTIL |
Study First Received: | November 8, 2006 |
Last Updated: | November 26, 2006 |
ClinicalTrials.gov Identifier: | NCT00397267 |
Health Authority: | Israel: Ministry of Health |
Dyspnea Cough |
Hypersensitivity Lung Diseases, Obstructive Respiratory Tract Diseases Lung Diseases Hypersensitivity, Immediate |
Cough Asthma Dyspnea Respiratory Hypersensitivity |
Immune System Diseases Bronchial Diseases |